The Japanese Pharmaceutical Industry: The New Drug Lag and the Failure of Industrial Policy by L. G. Thomas III

BUY IT NEW

  • $115.00 Online price
    $92.00 Member price
    (Save 20%)
    Limited Time Offer! Everyone receives the Member Price on books.
    See Details
    • skip to cart
  • Add To List uiAction=GetAllLists&page=List&pageType=list&ean=9781840645804&productCode=BK&maxCount=100&threshold=3

GET FREE SHIPPING ON ORDERS OF $25 OR MORE

DELIVERY & GIFT DETAILS:

Usually ships within 24 hours

Delivery Time and Shipping Rates

Eligible for gift wrap & gift message.

BUY IT USED

3 copies from $67.50

See All Available

(Hardcover)

  • Pub. Date: October 2001
  • 232pp

    Reader Rating:

    See All Detailed Ratings

    Buy it Used: 3 copies from $67.50 See All Available

    Customers who bought this also bought

     
    • Overview
    • Features

    Product Details

    • Pub. Date: October 2001
    • Publisher: Edward Elgar Publishing, Incorporated
    • Format: Hardcover, 232pp

    Synopsis

    Thomas (organization and management, Goizueta Business School at Emory U.) presents an analysis of the nature, causes, and consequences of the current drug lag in Japan. Coverage includes the magnitude and nature of the situation, in contrast with the 1970s drug lag in the U.S.; industrial policy and domestic ecosystems and the effects on pharmaceutical innovation, production, and consumption; key features of the Japanese ecosystem, their interactions, and pathologies of the system as a whole; the mechanisms of delay and exclusion for new drugs in Japan; and remedies for the new drug lag from the perspective of a U.S. government interest in sustaining and promoting global pharmaceutical innovation. For academics, experts in government and industry, researchers and students of industrial policy, economics, public health and trade policy. Annotation c. Book News, Inc., Portland, OR (booknews.com)

    Customer Reviews

    • Reader Rating:

    Be the first to write a review!